4-O-α-D-glucopyranosylmoranoline

Metabolite details

Identifier

GNVIYGFSOIHFHK-NIKVEEOSSA-N

InChI Key

GNVIYGFSOIHFHK-NIKVEEOSSA-N

IUPAC name

(2R,3R,4R,5S)-4,5-dihydroxy-2-(hydroxymethyl)piperidin-3-yl α-D-glucopyranoside

Preferred name

4-O-α-D-glucopyranosylmoranoline

INN name

—

Synonym

α-D-glucopyranosyl-(1→4)-1-deoxynojirimycin

ChEBI

CHEBI:70736

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose